查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363423

美国事后紧急避孕药市场规模、份额和趋势分析报告：按类型、配销通路、地区和细分市场预测，2023-2030 年

U.S. Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Ulipristal Acetate), By Distribution Channel (Retail Store, Online Store), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国事后紧急避孕药市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，美国事后紧急避孕药(ECP) 市场预计将达到 51 亿美元。

预计2023年至2030年该市场将以5.24%的年复合成长率成长。育龄妇女对 ECP 的接受度不断提高预计将成为成长的动力。随着越来越多的女性意识到紧急避孕的重要性和有效性，市场预计将进一步扩大，以满足对方便可靠的避孕选择不断增长的需求。

由于意外怀孕的增加，预计该市场将会成长。这些怀孕会对女性的健康、教育、职业和家庭生活产生负面影响。根据全国家庭成长调查，2017年，有意外怀孕风险的20至44岁女性中，60.3%使用了有效的避孕方法。这些资料凸显了对可靠的紧急避孕选择的需求，从而导致市场成长，以满足寻求避免意外怀孕的女性不断增长的需求。

主要企业正在实施联盟、併购、业务扩张和新产品发布等各种策略，以扩大其市场份额。这些策略倡议预计将有助于市场成长。例如，2023 年 4 月，生产非处方紧急避孕药和其他保健品的私人公司Foundation Consumer Healthcare 正在考虑价值 40 亿日圆的潜在销售。该公司于 2017 年从总公司Teva Pharmaceutical Industries收购Plan B One-Step 等事后紧急避孕药品牌而受到关注。此举帮助公司获得了市场的显着认可。

美国事后紧急避孕药市场报告亮点

  • 从产品类型来看，由于不同市场参与企业的多种产品的推出以及比其他选择更高的成功率，黄体酮锭剂在 2022 年占据最大市场占有率，超过 45%。
  • 按配销通路，零售店细分市场在预测期内占据最大收益占有率，到 2022 年将超过 55%。在美国，提供来自不同市场参与者的多样化产品的药局数量正在增加，预计将推动市场成长。
  • 线上商店部门预计在预测期内成长最快。在美国，网路存取的改善和妇女对事后紧急避孕药认识的提高预计将推动该领域的成长。
  • 东南亚地区在 2022 年占据最大的市场占有率，主要是由于意外怀孕的患病不断上升。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 营商环境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第4章按类型分類的业务分析

  • 美国事后紧急避孕药市场：类型变异分析和市场占有率，2022 年和 2030 年
  • 美国事后紧急避孕药市场：细分仪表板
  • 避孕药
  • 黄体酮剂
  • 醋酸乌利司他

第5章配销通路业务分析

  • 美国事后紧急避孕药市场：2022年和2030年配销通路变化分析和市场占有率
  • 美国事后紧急避孕药市场：细分仪表板
  • 零售店
  • 网路商城
  • 其他的

第6章区域业务分析

  • 按地区划分：2022 年和 2030 年美国事后紧急避孕药市场
  • 东北
  • 东南
  • 中西部
  • 西
  • 西南

第7章竞争形势

  • 公司分类
  • 策略规划
    • 扩张
    • 获得
    • 合作
    • 新产品发布
    • 其他的
  • 公司简介/名单
    • Afaxys Pharma LLC
    • Teva Pharmaceutical Industries Ltd.
    • Syzygy Healthcare, LLC
    • Gedeon Richter USA, Inc.
    • Rapha Pharmaceuticals, Inc.
    • Perrigo Company plc.
    • Foundation Consumer Healthcare LLC
    • Wockhardt USA
    • Pfizer Inc.
    • Bayer plc
Product Code: GVR-4-68040-110-9

U.S. Emergency Contraceptive Pills Market Growth & Trends:

The U.S. emergency contraceptive pills (ECPs) market size is expected to reach USD 5.1 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 5.24% from 2023 to 2030. The rising acceptance of ECPs among women of reproductive age is expected to drive the growth. As more women recognize the importance of emergency contraception and its effectiveness, the market is expected to witness further expansion to meet the increasing demand for accessible and reliable contraceptive options.

The market is anticipated to grow owing to the increasing incidence of unintended pregnancies. These pregnancies can adversely affect women's health, education, career, and family life. According to The National Survey of Family Growth, in 2017, 60.3% of women aged 20 to 44 years at risk of unintended pregnancy used effective contraceptive methods. This data highlights the need for reliable emergency contraception options, leading to the market's growth in response to the increasing demand from women who want to avoid unintended pregnancies.

Key players are implementing various strategies such as partnerships, mergers & acquisitions, expansions, and launching new products to expand their market presence. These strategic initiatives are expected to contribute to the market's growth. For instance, in April 2023, Foundation Consumer Healthcare, a private company manufacturing over-the-counter emergency contraceptive pills and healthcare products, is considering a potential sale worth 4 billion. The company gained prominence in 2017 when it acquired emergency contraception brands like Plan B One-Step from Teva Pharmaceutical Industries, based in Israel. This move contributed to the company's significant recognition in the market.

U.S. Emergency Contraceptive Pills Market Report Highlights:

  • Based on type, the progesterone pills segment held the largest market share of over 45% in 2022, owing to the introduction of multiple products from various market players and a high success rate over other options
  • Based on distribution channel, the retail store segment held the largest revenue share of over 55% in 2022 during the forecast period. An increasing number of pharmacies in the U.S. that offers a diverse range of products from different market player is expected to drive the market growth
  • The online store segment is anticipated to witness the fastest growth during the forecast period. The increasing internet accessibility and growing awareness among women about emergency contraceptives in the U.S. are expected to fuel the segment's growth
  • The Southeast region held the largest market share in 2022, primarily due to the increasing prevalence of unplanned pregnancies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources & Third-Party Perspectives
    • 1.4.4. Primary Research
  • 1.5. Information Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing awareness about emergency contraception methods
      • 3.3.1.2. Rising prevalence of unintended pregnancies
      • 3.3.1.3. Increased focus on women's health by the government and non-government organizations.
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recall
      • 3.3.2.2. Adverse effects associated with the use of contraceptive drugs
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. U.S. Emergency Contraceptive Pills Market: Type Movement Analysis & Market Share, 2022 & 2030
  • 4.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
  • 4.3. Combination Pills
    • 4.3.1. Combination Pills Market, 2018 - 2030 (USD Million)
  • 4.4. Progesterone Pills
    • 4.4.1. Progesterone Pills Market, 2018 - 2030 (USD Million)
  • 4.5. Ulipristal Acetate
    • 4.5.1. Ulipristal Acetate Market, 2018 - 2030 (USD Million)

Chapter 5. Distribution Channel Business Analysis

  • 5.1. U.S. Emergency Contraceptive Pills Market: Distribution Channel Movement Analysis & Market Share, 2022 & 2030
  • 5.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
  • 5.3. Retail Store
    • 5.3.1. Retail Store Market, 2018 - 2030 (USD Million)
  • 5.4. Online Store
    • 5.4.1. Online Store Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. U.S. Emergency Contraceptive Pills Market by Region, 2022 & 2030
  • 6.2. Northeast
    • 6.2.1. Northeast Market, 2018 - 2030 (USD Million)
  • 6.3. Southeast
    • 6.3.1. Southeast Market, 2018 - 2030 (USD Million)
  • 6.4. Midwest
    • 6.4.1. Midwest Market, 2018 - 2030 (USD Million)
  • 6.5. West
    • 6.5.1. West Market, 2018 - 2030 (USD Million)
  • 6.6. Southwest
    • 6.6.1. Southwest Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Expansion
    • 7.2.2. Acquisition
    • 7.2.3. Collaborations
    • 7.2.4. New Product Launches
    • 7.2.5. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. Afaxys Pharma LLC
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Teva Pharmaceutical Industries Ltd.
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Syzygy Healthcare, LLC
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Gedeon Richter USA, Inc.
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Rapha Pharmaceuticals, Inc.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Perrigo Company plc.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Foundation Consumer Healthcare LLC
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Wockhardt USA
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Pfizer Inc.
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Bayer plc
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Emergency Contraceptive Pills market, by Type, 2018 - 2030 (USD Million)
  • Table 4. U.S. Emergency Contraceptive Pills market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5. U.S. Emergency Contraceptive Pills market, by Region, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Market research process
  • Fig 2. Information procurement
  • Fig 3. Primary research pattern
  • Fig 4. Market research approaches
  • Fig 5. Value chain-based sizing & forecasting
  • Fig 6. Market formulation & validation
  • Fig 7. U.S. emergency contraceptive pills market segmentation
  • Fig 8. Market snapshot, 2022
  • Fig 9. Segment snapshot
  • Fig 10. Competitive landscape snapshot
  • Fig 11. Market trends & outlook
  • Fig 12. Market driver relevance analysis (current & future impact)
  • Fig 13. Market restraint relevance analysis (current & future impact)
  • Fig 14. PESTLE analysis
  • Fig 15. Porter's five forces analysis
  • Fig 16. U.S. emergency contraceptive pills market: Type outlook and key takeaways
  • Fig 17. U.S. emergency contraceptive pills market: Type movement analysis
  • Fig 18. Combination pills market revenue, 2018 - 2030 (USD Million)
  • Fig 19. Progesterone pills market revenue, 2018 - 2030 (USD Million)
  • Fig 20. Ulipristal acetate market revenue, 2018 - 2030 (USD Million)
  • Fig 21. U.S. emergency contraceptive pills market: Distribution channel outlook and key takeaways
  • Fig 22. U.S. emergency contraceptive pills market: Distribution channel movement analysis
  • Fig 23. Retail store market revenue, 2018 - 2030 (USD Million)
  • Fig 24. Online store market revenue, 2018 - 2030 (USD Million)
  • Fig 25. Others market revenue, 2018 - 2030 (USD Million)
  • Fig 26. U.S. emergency contraceptive pills market: Regional outlook and key takeaways
  • Fig 27. U.S. emergency contraceptive pills market: Regional movement analysis
  • Fig 28. Northeast market revenue, 2018 - 2030 (USD Million)
  • Fig 29. Southeast market revenue, 2018 - 2030 (USD Million)
  • Fig 30. Midwest market revenue, 2018 - 2030 (USD Million)
  • Fig 31. West market revenue, 2018 - 2030 (USD Million)
  • Fig 32. Southwest market revenue, 2018 - 2030 (USD Million)
  • Fig 33. Company categorization
  • Fig 34. Strategy mapping
  • Fig 35. Company market position analysis